Abstract
BackgroundAn orally available small molecule capable of activating innate immune response can be an ideal drug candidate to enhance clinical benefit of existing immune related therapies in combination. Stimulator of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
